• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926016250
Device Problems Detachment Of Device Component (1104); Difficult to Remove (1528)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/27/2016
Event Type  Injury  
Manufacturer Narrative
  device is a combination product.(b)(4).  device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that catheter removal difficulties were encountered and shaft break occurred.The target lesion was located in the left internal mammary to left anterior descending (lad) artery.A 2.50x16mm synergy ii drug-eluting stent was properly and correctly deployed in the target lesion.The physician re-advanced the device to post dilate the stent using its balloon to make the sure that the stent was perfectly placed in the lesion.When the physician pulled the stent delivery system (sds), it got caught with the wire (part of the stent).The sds was removed but the distal portion of the shaft was left inside the patient's body.A snaring device was then used to remove the detached portion of the shaft.The implanted stent was fine.The procedure was completed.No patient complications were reported and the patient's status was fine.
 
Manufacturer Narrative
Device avail.For eval, returned to mfr.On, device returned to mfr, device evaluated by mfr, eval summary attached, method codes, result codes, conclusion codes updated.Device evaluated by mfr: a synergy ii, us, mr, 2.5 x 16 mm stent delivery system (sds) proximal end including the manifold was returned for analysis, the distal section from the distal end of the port weld to the tip was not returned.The stent was deployed during the procedure.A visual and tactile examination found an extrusion break 6-7 mm distal of port site.The port weld section appeared to be slit from the beginning to the end of the port weld section returned.The bi-component bond showed no signs of damage or strain.A visual and tactile examination of the device found severe hypotube kinks along the full catheter length.The hypotube tab was pulled proximally from its original position (beginning of the port weld) for a distance of 9 mm.Dried medium resembling blood was evident in the manifold.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event Description
It was reported that catheter removal difficulties were encountered and shaft break occurred.The target lesion was located in the left internal mammary to left anterior descending (lad) artery.A 2.50 x 16 mm synergy ii drug-eluting stent was properly and correctly deployed in the target lesion.The physician re-advanced the device to post dilate the stent using its balloon to make the sure that the stent was perfectly placed in the lesion.When the physician pulled the stent delivery system (sds), it got caught with the wire (part of the stent).The sds was removed but the distal portion of the shaft was left inside the patient's body.A snaring device was then used to remove the detached portion of the shaft.The implanted stent was fine.The procedure was completed.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6269545
MDR Text Key65504509
Report Number2134265-2017-00105
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840091
UDI-Public(01)08714729840091(17)20170422(10)0019212036
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/23/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/22/2017
Device Model NumberH7493926016250
Device Catalogue Number39260-1625
Device Lot Number0019212036
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/17/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-